Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Wearable ultrasound gadget zaps brain to boost dream sleep

NCT ID NCT07190287

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a wearable system that records brain waves and delivers gentle ultrasound to deep brain areas during REM sleep. Fifty-two healthy adults and people with mild sleep or stress issues wore the device for two nights. The goal was to see if it safely increases REM sleep and improves stress-related measures, helping guide future sleep therapies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

52 people

The number who actually took part.

Started

Jul 2025

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 50 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria for Healthy Volunteers: \- Adults aged 18-50, willing and able to undergo MRI, EEG, and FUS experiments. Inclusion Criteria for Healthy Volunteers with Non-Clinical Sleep Disturbances: * Adults aged 18-50, willing and able to undergo EEG and FUS experiments. * Pittsburgh Sleep Quality Index (PSQI) score between 5 and 10. * Perceived Stress Scale (PSS) score between 16 and 21. Exclusion Criteria for Both Groups: * Current or past history of psychopathology, epilepsy, or other seizure disorders. * Inability to provide informed consent to undergo EEG recording, FUS stimulation, and MRI. * Diagnosed sleep disorders (e.g., insomnia, obstructive sleep apnea). * Contraindications to FUS or MRI, including but not limited to: history of stroke, brain tumors, brain hemorrhages, internal wires, electrodes, pacemakers, implants, irremovable ferromagnetic objects in the head that are unsafe for MRI and/or cause large imaging artifacts, brain surgery, moderate-to-severe head injury, any penetrating head injury, or uncontrolled thyroid disorder. * Pregnant individuals or those attempting to become pregnant (due to unknown MRI-related risks to fetuses). * Serious medical illnesses likely to interfere with study participation. * Current active suicidal or homicidal ideation (or suicide attempt within the past 3 months). * Current substance use disorder. * Current or recent (within the past 3 months) psychotic symptoms. * Currently meeting diagnostic criteria for a manic episode. * Currently engaged in evidence-based or experimental treatments (e.g., weekly cognitive behavioral therapy, transcranial magnetic stimulation, ketamine/esketamine treatment) other than psychiatric medications that have been on a stable dosage and regimen for at least 3 months (including antidepressants, mood stabilizers, atypical antipsychotics, and sedatives/hypnotics), in order to avoid confounding therapeutic effects.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Rem sleep measurement are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Parasomnias sleep disorder Stress, Psychological

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • UT Austin, Biomedical Engineering Department

    Austin, Texas, 78712, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.